Pharma Journalist -

Aro Biotherapeutics, a clinical stage biotechnology company pioneering the development of tissue-targeted genetic medicines, announced it has secured $41.5M in a Series B funding round.…
Read More...

AmacaThera, a leader in the development of novel injectable, localized therapeutics based upon its AmacaGel delivery platform, announced the closing of a CAD$4.0 million financing…
Read More...

PRISM BioLab, Co. Ltd. announced that it has entered into a License and Collaboration Agreement with Eli Lilly and Company ("Lilly"). Under the agreement, PRISM and Lilly will…
Read More...

Boehringer Ingelheim and IBM announced an agreement that will enable Boehringer to use IBM’s foundation model technologies to discover novel candidate antibodies for the development…
Read More...

AbbVie announced updates from the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) for epcoritamab, an investigational T-cell engaging bispecific antibody…
Read More...

Genelux Corporation announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for the development program of Olvi-Vec (olvimulogene…
Read More...

Vertex Pharmaceuticals Incorporated announced that the European Commission has granted approval for the label expansion of KAFTRIO (ivacaftor/tezacaftor/elexacaftor) in a combination…
Read More...

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development licensing…
Read More...

Boehringer Ingelheim, a global leader in animal health, has received marketing authorization from the European Commission for SENVELGO (active ingredient: velagliflozin), marking a…
Read More...

Boehringer Ingelheim announced the acquisition of privately-held T3 Pharmaceuticals AG (“T3 Pharma”), a clinical stage Swiss biotech company, for an amount of up to 450 million CHF.…
Read More...